CVR: 39807556
Ebumab Holding ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Ikke-finansielle hovedsæders aktiviteter. The management consists of Hans Heugh Wandall and Johan Henrik Faber. The company's owners include Wandall Holding ApS, Johan H. Faber ApS and Batchelor Holding ApS. In 2025, the company reported a gross profit of DKK -86,871 and a net result of DKK 75,634,949 compared with DKK -39,197 the year before. Equity amounted to DKK 5,684,083.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at eje aktier og anparter i koncernforbundne selskaber samt anden efter bestyrelsens skøn forbundet virksomhed.
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 515 companies in Ikke-finansielle hovedsæders aktiviteter
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Ebumab Holding ApS has published its annual report for 2025. Gross profit came to DKK -86,871, and the net result was DKK 75,634,949.
Ebumab Holding ApS has published its annual report for 2024. Gross profit came to DKK -16,250, and the net result was DKK -39,197.
As of February 25, 2025, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Ebumab Holding ApS.
As of February 25, 2025, Slotsgade Revision ApS has stepped down as auditor of Ebumab Holding ApS.
Ebumab Holding ApS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK 171,331.
As of September 1, 2023, Mads Nikolaj Behrndt-Eriksen has joined the board of directors of Ebumab Holding ApS.
Ebumab Holding ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK 100,146.
As of August 24, 2023, Slotsgade Revision ApS has been appointed auditor of Ebumab Holding ApS.
As of August 24, 2023, Hans Heugh Wandall has joined the board of directors of Ebumab Holding ApS.
As of August 24, 2023, Johan Henrik Faber has joined the board of directors of Ebumab Holding ApS.
As of August 24, 2023, Søren Erik Bjørn has joined the board of directors of Ebumab Holding ApS.
As of August 24, 2023, Thomas Dal Stenfeldt Batchelor has joined the board of directors of Ebumab Holding ApS.
As of August 24, 2023, Hans Heugh Wandall is registered as director of Ebumab Holding ApS.
As of August 24, 2023, Johan Henrik Faber is registered as director of Ebumab Holding ApS.
As of August 15, 2023, Slotsgade Revision ApS has stepped down as auditor of Ebumab Holding ApS.
As of August 15, 2023, Hans Heugh Wandall has left the board of directors of Ebumab Holding ApS.
As of August 15, 2023, Johan Henrik Faber has left the board of directors of Ebumab Holding ApS.
As of August 15, 2023, Søren Erik Bjørn has left the board of directors of Ebumab Holding ApS.
As of August 15, 2023, Thomas Dal Stenfeldt Batchelor has left the board of directors of Ebumab Holding ApS.
As of August 15, 2023, Hans Heugh Wandall has stepped down as director of Ebumab Holding ApS.
As of August 15, 2023, Johan Henrik Faber has stepped down as director of Ebumab Holding ApS.
Ebumab Holding ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK 163,253.
Ebumab Holding ApS has published its annual report for 2020. Revenue came to DKK 785,388, and the net result was DKK -337,322.
As of December 14, 2020, Batchelor Holding ApS is registered as an owner of Ebumab Holding ApS with an ownership share of 10%.
As of December 14, 2020, Mabe Invest ApS is registered as an owner of Ebumab Holding ApS with an ownership share of 5%.
As of November 25, 2020, Johan H. Faber ApS is registered as an owner of Ebumab Holding ApS with an ownership share of 50%.
Ebumab Holding ApS has published its interim report for the period August 24, 2018 – December 31, 2019.
As of July 15, 2020, Slotsgade Revision ApS has been appointed auditor of Ebumab Holding ApS.
As of July 15, 2020, KAPPELSKOV REVISION. GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of Ebumab Holding ApS.
As of June 22, 2020, Hans Heugh Wandall has joined the board of directors of Ebumab Holding ApS.
As of June 22, 2020, Søren Erik Bjørn has joined the board of directors of Ebumab Holding ApS.
As of June 22, 2020, Kim Stengaard Holmsted has left the board of directors of Ebumab Holding ApS.
As of June 22, 2020, Wandall Holding ApS is registered as an owner of Ebumab Holding ApS with an ownership share of 15%.
As of June 22, 2020, GV1 Holding ApS is registered as an owner of Ebumab Holding ApS with an ownership share of 5%.
As of June 21, 2020, Hans Heugh Wandall has left the board of directors of Ebumab Holding ApS.
As of June 1, 2019, Johan Henrik Faber has joined the board of directors of Ebumab Holding ApS.
As of June 1, 2019, Thomas Dal Stenfeldt Batchelor has joined the board of directors of Ebumab Holding ApS.
As of June 1, 2019, Kurt Flemming Holmsted has left the board of directors of Ebumab Holding ApS.
As of June 1, 2019, Johan Henrik Faber is registered as director of Ebumab Holding ApS.
As of June 1, 2019, Kurt Flemming Holmsted has stepped down as director of Ebumab Holding ApS.
As of March 12, 2019, Hans Heugh Wandall is registered as director of Ebumab Holding ApS.
As of August 24, 2018, KAPPELSKOV REVISION. GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of Ebumab Holding ApS.
As of August 24, 2018, Kurt Flemming Holmsted has joined the board of directors of Ebumab Holding ApS.
As of August 24, 2018, Hans Heugh Wandall has joined the board of directors of Ebumab Holding ApS.
As of August 24, 2018, Kim Stengaard Holmsted has joined the board of directors of Ebumab Holding ApS.
As of August 24, 2018, Kurt Flemming Holmsted is registered as director of Ebumab Holding ApS.
Ebumab Holding ApS was founded on August 24, 2018.
Companies in the same industry and area
CVR 38262416
CVR 38700081
CVR 23075210
CVR 56873619
CVR 44525380
companydata.dk